I work at the intersection of two worlds that rarely speak the same language: the disciplined, capital-intensive world of Korean industrial conglomerates, and the fast, founder-driven world of American open innovation. My career has been about building the bridge between them — and pointing it toward problems that matter.

My foundation is technical. I studied Chemical Engineering at Yonsei University, where my graduate thesis examined the wearable technology market through input-output economic analysis — an early signal of where connected devices and human health were heading. I spent my first years in manufacturing, building battery safety materials for lithium-ion cells and LCD optical films for flat panels. That grounding in materials and process engineering shapes how I evaluate hardware-dependent health technologies today.

From 2011 to 2015, I ran global business development and go-to-market for IoT devices and wearables across 17 markets. These weren't academic exercises — they were products in the hands of consumers, with revenue targets, channel partners, and real regulatory environments. The wearables market of 2012 was primitive by today's standards, but the fundamental challenge — getting connected hardware to people at scale — is identical to the remote patient monitoring problem I work on now.

Between 2016 and 2022, I operated out of the LG Group Chairman's Office, working on conglomerate-level strategy and bilateral economic diplomacy. I built the Technology Exchange CEO Forum — a cross-affiliate program that connected 40+ senior executives across LG's global businesses and generated over $30M in collaborative revenue. I managed Korea–U.S., Korea–Japan, and Korea–China Presidential Summit business agendas. This period gave me an unusually clear view of how industrial capital at scale moves — and how slowly it moves without the right translation layer.

The translation layer is what I've spent the last several years building. The open innovation ecosystem I help design and operate screens over 1,000 startups annually, advances the strongest through a structured stage-gate process, and has produced four independent spinoff companies focused on digital health and AI. The West Virginia Initiative — a government-backed program deploying healthtech ventures in rural Appalachia — is the most concrete expression of what I believe: that the gap between innovation and access is a design problem, and it's solvable.

I am a Patent Review & Assessment Committee Member at Seoul National University's R&DB Foundation, evaluating IP in Electronics, AI, and Telecommunications. I hold a CFA Institute Certificate in ESG Investing and a Venture Capital Specialist certification, both pursued independently. I completed my MBA at London Business School, concentrating in Strategy and Finance/Private Equity, as one of 10 annual recipients of the LG Group Corporate Sponsorship.